About Pulmonary Artery Pressure Monitoring | Abbott
CARDIOVASCULAR
hamburger
Live More Worry Less

About Pulmonary Artery Pressure Monitoring

What is Pulmonary Artery Pressure?

Each time blood passes through your heart, the right ventricle of your heart (the chambers on the lower right side) pump blood to your lungs through a large blood vessel. That large blood vessel is the pulmonary artery.

Pulmonary blood pressure (the pressure of your pulmonary artery) reflects the amount of force your heart is exerting to pump blood from your heart to your lungs. If your heart has to work harder to pump that blood, then your pulmonary artery (PA) pressure goes up.

What is Pulmonary Artery Pressure Monitoring?

A Swan Ganz™ catheter (also known as a PA catheter) has been used for more than 30 years to monitor heart and lung function but is not designed for permanent monitoring of heart failure.

Modern PA pressure monitoring systems (sometimes also referred to as pulmonary pressure monitoring devices) such as the CardioMEMS HF System includes a permanent pressure-sensing device that can track and analyze the pressure in your pulmonary artery remotely from the comfort of your own home.

Diagram of a PA Sensor of the CardioMEMS HF System being inserted into the pulmonary artery next to a patient electronic system and a laptop.

The CardioMEMS HF System is:

  • A small, implantable wireless sensor and remote heart failure monitoring platform
  • Designed specifically for the remote monitoring and management of congestive heart failure
  • Fastest growing, clinically proven, PA pressure monitor that significantly reduces heart failure hospital admissions and improves quality of life.1

What does Pulmonary Artery Pressure Tell Doctors?

Changes in PA pressure is an early indicator of worsening heart failure. If doctors can see these early changes, they can potentially make simple adjustments to your care that will help with heart failure management. These adjustments might include changes to medications and/or lifestyle.

Other signs of worsening heart failure can appear too late to prevent hospitalization or other larger adjustments to care, which is why pulmonary artery pressure monitoring can be a beneficial treatment option.

References

  1. Abraham, W. T., Adamson, P. B., Bourge, R. C., Aaron, M. F., Costanzo, M. R., Stevenson, L. W., … Yaday, J. S. (2011). Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: A randomised controlled trial. The Lancet, 377(9766), 658-666. n=550. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(11)60101-3/fulltext
     

Swan Ganz is a trademark of the Edwards Lifesciences Corporation.

MAT-2116641 v2.0

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.

False
accessibility
© 2021 Abbott. All Rights Reserved. Please read the Legal Notice for further details.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

accessibility

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.